Anthony J. Maddaluna

CIK: 0001566333

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INDP

Indaptus Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

INDP
Indaptus Therapeutics, Inc.
Jun 10, 2025
Award(A)
Stock Option (right to buy)
Direct
12.5K shares-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
500 shares at avg. $0.50-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
250 shares at avg. $0.50-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
250 shares at avg. $0.50-

		Type	Shares	Price		Ownership
Jun 10, 2025	INDP Indaptus Therapeutics, Inc.	Award(A) Stock Option (right to buy)	12,500	-	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	500	$0.50	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	250	$0.50	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	250	$0.50	-	Direct

1-4 of 4 transactions

About MADDALUNA ANTHONY J

MADDALUNA ANTHONY J (SEC CIK 0001566333) files insider reports with the SEC as Director of Indaptus Therapeutics, Inc. (INDP).

Signal8 holds 2 ownership filings by MADDALUNA ANTHONY J, all Form 4s, filed between Apr 11, 2025 and Jun 11, 2025. Those filings report 4 transactions, from Apr 10, 2025 to Jun 10, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on MADDALUNA ANTHONY J's filings is in NEW YORK, NY.

Recent filings by MADDALUNA ANTHONY J

Jun 10, 2025: Grant or award of INDP derivative securities (Form 4, code A).
Apr 10, 2025: Disposition to issuer transactions of INDP derivative securities (3 lines, Form 4, code D).

Other insiders filing for Indaptus Therapeutics, Inc. (INDP)

Lu Qinglai, Director
Yao Yun, 10% Owner
SINO LION VENTURES Ltd, 10% Owner
Dai Junyi, Chief Executive Officer
Lazar David E., Director
Jabbour Jerome D, Director

How to read Form 4 transaction codes